Drug resistance; Elimination; Malaria; Mosquito control; Plasmodium falciparum; Plasmodium vivax; Policy making; Surveillance; WHO
Indexed keywords
MALARIA VACCINE;
PRIMAQUINE;
ADVISORY COMMITTEE;
BIOGEOGRAPHIC REGION;
CONFERENCE PAPER;
CONSULTATION;
DISEASE ELIMINATION;
EVIDENCE BASED MEDICINE;
FEASIBILITY STUDY;
GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HUMAN;
INFORMATION DISSEMINATION;
MALARIA;
MEDICAL DECISION MAKING;
MEDICAL TERMINOLOGY;
MOSQUITO;
NONHUMAN;
PLASMODIUM FALCIPARUM;
PLASMODIUM VIVAX;
POINT OF CARE TESTING;
PRACTICE GUIDELINE;
PREGNANCY;
SWITZERLAND;
TREATMENT INDICATION;
VACCINATION;
WORLD HEALTH ORGANIZATION;
Inaugural meeting of the malaria policy advisory committee to the WHO: Conclusions and recommendations
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2012) Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations. Malar J 11:137
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of September 2012 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2012) Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J 11:424
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of March 2013 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2013) Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting. Malar J 12:213
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of September 2013 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2013) Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar J 12:456
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of March 2014 meeting
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2014) Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2014 meeting. Malar J 13:253
Malaria Policy Advisory Committee to the WHO: Conclusions and recommendations of sixth biannual meeting (September 2014)
WHO Malaria Policy Advisory Committee and Secretariat
WHO Malaria Policy Advisory Committee and Secretariat (2014) Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014). Malar J 14:107
presented by Pedro Alonso on behalf of the global malaria team on 5 March
Report from the Global Malaria Programme, presented by Pedro Alonso on behalf of the global malaria team on 5 March 2015. http://www.who.int/malaria/mpac/mpac-mar2015-director-update.pdf
Guidance on temporary malaria control measures in Ebola-affected countries, 13 November 2014. http://www.who.int/malaria/publications/atoz/malaria-control-ebola-affected-countries/en/
Towards a malaria-free world: a global case for investment and action 2016-2030, update from Roll Back Malaria, presented on 5 March 2015. http://www.who.int/malaria/mpac/mpac-mar2015-RBM-report.pdf
Homepage of the Global Malaria Action Plan (GMAP2). http://www.gmap2.org/english/home
16
84938559737
Background document for session 3
Malaria elimination strategy in the Greater Mekong subregion. Background document for session 3. http://www.who.int/malaria/mpac/mpac-march2015-gms-briefing-note.pdf
Expert Review Group findings: point-of-care G6PD diagnostics, presented on 6 March 2015. http://www.who.int/malaria/mpac/mpac-mar2015-erg-g6pd-presentation.pdf
Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria
Background document for session 6, presented on 6 March 2015
Point-of-care G6PD testing to support safe use of primaquine for the treatment of vivax malaria, WHO Evidence Review Group meeting report. Background document for session 6, presented on 6 March 2015. http://www.who.int/malaria/mpac/mpac-march2015-erg-g6pd.pdf
Vector Control Advisory Group (VCAG) report, presented on 6 March 2015
Providing a pathway forward for novel paradigms in vector control. Vector Control Advisory Group (VCAG) report, presented on 6 March 2015. http://www.who.int/malaria/mpac/mpac-mar2015-vcag-report.pdf
Proposal for an Evidence Review Group on intermittent screening and treatment and safety of artemisinin in pregnancy. Background document for session 4. http://www.who.int/malaria/mpac/mpac-march2015-erg-mip.pdf
Manuscripts for the WHO Evidence Review Group for malaria in pregnancy (MiP-ERG), July 2015. Background document for session 4. http://www.who.int/malaria/mpac/mpac-march2015-erg-mip-manuscripts.pdf
Update on the WHO Global Malaria Programme strategy refresh. Background document for session 2. http://www.who.int/malaria/mpac/mpac-march2015-strategy-refresh.pdf
Update on policy-setting by the WHO Global Malaria Programme, presented on 5 March 2015. http://www.who.int/malaria/mpac/mpac-mar2015-policy-setting.pdf
Update on policy-setting by the WHO Global Malaria Programme. Background document for session 2. http://www.who.int/malaria/mpac/mpac-march2015-gmp-policy-setting.pdf
Malaria Policy Advisory Committee (MPAC) March 2015 meeting list of participants. http://www.who.int/malaria/mpac/mpac-march2015-list-of-participants.pdf
